Beyond Meat Delays Annual Report Filing; Shares Preliminary Q4 Revenue

• The company expects to file its delayed Form 10-K by March 31 and is developing a remediation plan for its internal control procedures
• Q4 preliminary revenue of $61 million fell short of the $62.6 million analyst estimate, while full-year 2025 guidance of $275 million also trails the $276.5 million consensus
• Beyond Meat has not yet determined the potential impact of its inventory review on financial statements and plans to report full Q4 results on March 25

Beyond Meat Delays Annual Report Filing; Shares Preliminary Q4 Revenue

Beyond Meat announced Monday it will delay filing its 2025 annual report (Form 10-K), citing material weaknesses in internal financial controls. The plant-based meat maker expects to file by March 31 and plans to release Q4 results after market close on March 25.

Key Financial Figures:

• Preliminary Q4 revenue: approximately $61 million (below Wall Street estimates of $62.6 million)
• Full-year 2025 revenue guidance: approximately $275 million (versus analyst estimates of $276.5 million)

Core Issue:

The company requires additional time to complete a review of inventory balances, specifically examining amounts recorded for excess and obsolete inventory. Beyond Meat has not yet determined the potential impact of this review on its financial statements.

Management Response:

The company is reviewing its internal control procedures and developing a remediation plan to address the identified weaknesses in financial oversight.

Market Implications:

The delayed filing and missed revenue estimates signal ongoing operational challenges for Beyond Meat, which has struggled with declining demand for plant-based meat alternatives. The material weakness disclosure raises concerns about financial reporting reliability and inventory management practices. This development adds to existing headwinds facing the company and broader plant-based protein sector, which has experienced weakening consumer demand and increased competition.

The inventory review suggests potential write-downs may be forthcoming, which could further pressure the company's already challenged financial performance. Investors should monitor the March 25 earnings release for clarification on the magnitude of inventory adjustments and management's remediation timeline.